Last updated: 28 May 2021 at 7:09pm EST

Kalevi Kurkijarvi Net Worth




The estimated Net Worth of Kalevi Kurkijarvi is at least $1.38 Milion dollars as of 17 February 2021. Kalevi Kurkijarvi owns over 6,000 units of FibroGen Inc stock worth over $15,640 and over the last 10 years he sold FGEN stock worth over $947,080. In addition, he makes $417,378 as Independent Director at FibroGen Inc.

Kalevi Kurkijarvi FGEN stock SEC Form 4 insiders trading

Kalevi has made over 42 trades of the FibroGen Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 6,000 units of FGEN stock worth $171,900 on 17 February 2021.

The largest trade he's ever made was exercising 12,000 units of FibroGen Inc stock on 12 December 2017 worth over $34,800. On average, Kalevi trades about 3,755 units every 30 days since 2014. As of 17 February 2021 he still owns at least 39,100 units of FibroGen Inc stock.

You can see the complete history of Kalevi Kurkijarvi stock trades at the bottom of the page.





Kalevi Kurkijarvi biography

Dr. Kalevi Kurkijarvi Ph.D. serves as Independent Director of the Company. He has also served on the board of directors of our subsidiary, FibroGen Europe Oy, since November 1997, and as Managing Director (Chief Executive Officer) since January 2019. Dr. Kurkijärvi has been the Chairman and Founding Partner of Innomedica Oy, a business development company specialized in licensing, distributor search, and strategic planning for companies in the pharmaceutical, diagnostics, and biotechnology industries, since March 2010, and from August 1997 to February 2010 he acted as Director having financial matters as his main responsibility. He was also the Founding Partner and former Chairman and Chief Executive Officer of Bio Fund Management Ltd, a Finnish-Danish venture capital company, from 1997 until 2010. He has also been Chairman and Chief Executive Officer of his family’s import-export trading company, Biketex Ltd, since October 1993. Dr. Kurkijärvi has more than twenty years’ experience in international life science business and over ten years in corporate finance. He currently serves on the boards of directors of Innomedica Oy (Chair), Biketex Ltd (Chair) and Idea Development ID Oy (Chair). He previously served on the boards of directors at other biotechnology companies such as of Paratek Pharmaceuticals Inc., Ark Therapeutics Plc, BioTie Therapies Plc (Chair), Hytest Oy (Chair), Stick Tech Oy (Chair), Hormos Medical Oy (Chair), Map Medical Oy (Chair), Bio Orbit Oy (Chair) and Juvantia Pharma Oy, among others. Prior to founding Bio Fund, Dr. Kurkijärvi worked as Executive Director of the venture capital group at the Finnish National Fund of Research and Development (SITRA). He has also served as Executive Vice President at Wallac Oy, and as President and Chief Executive Officer of Pharmacia Diagnostics Production Oy. Dr. Kurkijärvi received a Doctor of Philosophy degree in Biochemistry and Molecular Biology from the University of Turku in 1992, where he also worked for several years in research and teaching.

What is the salary of Kalevi Kurkijarvi?

As the Independent Director of FibroGen Inc, the total compensation of Kalevi Kurkijarvi at FibroGen Inc is $417,378. There are 17 executives at FibroGen Inc getting paid more, with Kin-Hung Yu having the highest compensation of $5,856,450.



How old is Kalevi Kurkijarvi?

Kalevi Kurkijarvi is 68, he's been the Independent Director of FibroGen Inc since 1996. There are 2 older and 20 younger executives at FibroGen Inc. The oldest executive at FibroGen Inc is Thomas Kearns, 83, who is the Lead Independent Director.

What's Kalevi Kurkijarvi's mailing address?

Kalevi's mailing address filed with the SEC is C/O FIBROGEN, INC., 409 ILLINOIS ST., SAN FRANCISCO, CA, 94158.

Insiders trading at FibroGen Inc

Over the last 10 years, insiders at FibroGen Inc have traded over $188,593,537 worth of FibroGen Inc stock and bought 106,523 units worth $1,309,423 . The most active insiders traders include Rory B Riggs, Thomas B Neff oraz Jeffrey William Henderson. On average, FibroGen Inc executives and independent directors trade stock every 8 days with the average trade being worth of $6,963. The most recent stock trade was executed by Deyaa Adib on 12 June 2024, trading 22,123 units of FGEN stock currently worth $25,884.



What does FibroGen Inc do?

fibrogen is a research-based biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs. the company has built upon its extensive research experience in fibrosis and hypoxia-inducible factor (hif) biology to generate clinical programs targeting multiple therapeutic areas. fibrogen's most advanced product candidate, roxadustat (fg-4592), is an oral small molecule inhibitor of hif prolyl hydroxylases (hif-phs), in phase 3 clinical development for the treatment of anemia in chronic kidney disease (ckd). our second product candidate, fg-3019, is a monoclonal antibody in phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (ipf), pancreatic cancer and liver fibrosis. for more information please visit: www.fibrogen.com.



What does FibroGen Inc's logo look like?

FibroGen Inc logo

Complete history of Kalevi Kurkijarvi stock trades at FibroGen Inc

Data
#
Firma
Osoba
Trans.
Transakcja
Ilość akcji Cena za akcję Łączna cena Ilość akcji po Źródło
17 Feb 2021 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 6,000 $28.65 $171,900
17 Feb 2021
39,100
19 Jan 2021 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 6,000 $19.05 $114,300
19 Jan 2021
39,100
14 Jan 2021 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 5,999 $19.05 $114,281
14 Jan 2021
39,099
28 Dec 2020 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 6,001 $18.34 $110,058
28 Dec 2020
39,101
10 Feb 2020 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 6,000 $18.34 $110,040
10 Feb 2020
34,400
6 Jan 2020 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 6,000 $18.00 $108,000
6 Jan 2020
34,400
9 Dec 2019 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 6,000 $18.00 $108,000
9 Dec 2019
34,400
7 Nov 2019 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 6,000 $9.78 $58,680
7 Nov 2019
34,400
7 Oct 2019 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 6,000 $9.78 $58,680
7 Oct 2019
34,400
9 Sep 2019 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 6,000 $5.95 $35,700
9 Sep 2019
34,400
5 Aug 2019 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 6,000 $3.50 $21,000
5 Aug 2019
34,400
8 Jul 2019 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 6,000 $3.50 $21,000
8 Jul 2019
34,400
5 Jun 2019 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 6,000 $2.90 $17,400
5 Jun 2019
34,400
8 May 2019 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 6,000 $2.90 $17,400
8 May 2019
29,700
15 Apr 2019 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 4,000 $2.90 $11,600
15 Apr 2019
27,700
8 Apr 2019 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 4,000 $2.90 $11,600
8 Apr 2019
27,700
19 Dec 2018 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 4,000 $2.90 $11,600
19 Dec 2018
27,700
15 Nov 2018 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 4,000 $2.90 $11,600
15 Nov 2018
27,700
18 Oct 2018 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 4,000 $2.90 $11,600
18 Oct 2018
27,700
17 Sep 2018 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 4,000 $2.90 $11,600
17 Sep 2018
27,700
16 Aug 2018 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 4,000 $2.90 $11,600
16 Aug 2018
27,700
19 Jul 2018 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 4,000 $2.90 $11,600
19 Jul 2018
27,700
18 Jun 2018 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 4,000 $2.90 $11,600
18 Jun 2018
27,700
17 May 2018 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 4,000 $2.90 $11,600
17 May 2018
24,000
19 Apr 2018 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 4,000 $2.90 $11,600
19 Apr 2018
24,000
15 Mar 2018 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 4,000 $2.90 $11,600
15 Mar 2018
24,000
15 Feb 2018 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 6,000 $2.90 $17,400
15 Feb 2018
26,000
18 Jan 2018 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 6,000 $2.90 $17,400
18 Jan 2018
28,000
18 Dec 2017 Kalevi Kurkijarvi
Dyrektor
Sprzedaż 2,000 $42.80 $85,600
18 Dec 2017
22,000
12 Dec 2017 Kalevi Kurkijarvi
Dyrektor
Opcja Ćwiczenie 12,000 $2.90 $34,800
12 Dec 2017
36,000
17 Nov 2017 Kalevi Kurkijarvi
Dyrektor
Sprzedaż 2,000 $46.65 $93,300
17 Nov 2017
24,000
17 Oct 2017 Kalevi Kurkijarvi
Dyrektor
Sprzedaż 2,000 $52.24 $104,480
17 Oct 2017
26,000
17 Aug 2017 Kalevi Kurkijarvi
Dyrektor
Sprzedaż 4,000 $46.65 $186,600
17 Aug 2017
28,000
17 Jul 2017 Kalevi Kurkijarvi
Dyrektor
Sprzedaż 2,000 $33.45 $66,900
17 Jul 2017
32,000
15 Jun 2017 Kalevi Kurkijarvi
Dyrektor
Sprzedaż 2,000 $28.50 $57,000
15 Jun 2017
34,000
16 May 2017 Kalevi Kurkijarvi
Dyrektor
Sprzedaż 2,000 $27.40 $54,800
16 May 2017
36,000
17 Apr 2017 Kalevi Kurkijarvi
Dyrektor
Sprzedaż 2,000 $25.25 $50,500
17 Apr 2017
38,000
17 Apr 2017 Kalevi Kurkijarvi
Dyrektor
Sprzedaż 2,000 $25.25 $50,500
17 Apr 2017
38,000
16 Feb 2017 Kalevi Kurkijarvi
Dyrektor
Sprzedaż 2,000 $24.45 $48,900
16 Feb 2017
40,000
16 Feb 2017 Kalevi Kurkijarvi
Dyrektor
Sprzedaż 2,000 $24.45 $48,900
16 Feb 2017
40,000
19 Jan 2017 Kalevi Kurkijarvi
Dyrektor
Sprzedaż 2,000 $24.90 $49,800
19 Jan 2017
42,000
19 Jan 2017 Kalevi Kurkijarvi
Dyrektor
Sprzedaż 2,000 $24.90 $49,800
19 Jan 2017
42,000


FibroGen Inc executives and stock owners

FibroGen Inc executives and other stock owners filed with the SEC include: